Creutzfeldt-Jakob disease: Perceptions and realities of risk

Clinical and Experimental Ophthalmology

Volumn 34, Issue 7, 2006, Pages 635-636

  Moffatt, Louise S ^a   Pollock, Graeme A ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; PRION PROTEIN;

BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN BIOPSY; CODON; CORNEA TRANSPLANTATION; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; EDITORIAL; EPIDEMIC; EYEBANK; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INCIDENCE; ORGAN DONOR; PERCEPTION DISORDER; PRACTICE GUIDELINE; PREVALENCE; RECIPIENT; RISK ASSESSMENT; SURGICAL PATIENT; TISSUE TRANSPLANTATION; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED KINGDOM;

CORNEAL TRANSPLANTATION; CREUTZFELDT-JAKOB SYNDROME; EYE BANKS; HUMANS; IATROGENIC DISEASE; RISK FACTORS; SCLERA; TISSUE DONORS;

EID: 33748562472     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01387.x     Document Type: Editorial

References (15)

1. Tullo AB, Buckley RJ, Kelly T et al. Transplantation of ocular tissue from a donor with sporadic Creutzfeldt-Jakob disease. Clin Experiment Ophthalmol 2006; 34: 645-9.
2. Allan B, Tufts S. Transmission of Creutzfeldt-Jacob disease in corneal grafts. Br Med J 1997; 315: 1553-4.
3. Creutzfeldt-Jakob disease (CJD) and ophthalmology. London: Royal College of Ophthalmologists. Available from: http://www.rcophth.ac.uk/docs/ publications/CollegeCJDNov2003.pdf; and Guidance on the retrieval of human ocular tissue used in transplantation and research. London: Royal College of Ophthalmologists. Available from: http://www.rcophth.ac.uk/ docs/publications/OcularTissueAndTransplantation_.pdf
4. Brown P, Preece M, Brandel J-P et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55: 1075-81.
5. Department of Health's Policy and Guidance website on CJD: http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/ CJD/fs/en
6. Wadsworth JDF, Joiner S, Hill AF et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using highly-sensitive immunoblotting assay. Lancet 2001; 358: 171-80.
7. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Pre-clinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527-9.
8. Llewelyn CA, Hewitt PE, Knight RSG et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-21.
9. Hogan RN, Cavanagh HD. Transplantation of corneal tissue from donors with disease of the central nervous system. Cornea 1995; 14: 547-53.
10. Hilton DA. Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease. J Pathol 2006; 208: 134-41.
11. Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974; 290: 692-3.
12. Armstrong RA. Creutzfeldt-Jakob disease and vision. Clin Exp Optom 2006; 89: 3-9.
13. Lueck CJ, McIlwaine GC, Zeidler M. CJD and the eye. II. Ophthalmic and non-ophthalmic features. Eye 2000; 14: 291-301.
14. S-Juan P, Ward HJT, De Silva R, Knight RSG, Will RG. Ophthalmic surgery and Creutzfeldt-Jakob disease. Br J Ophthalmol 2004; 88: 446-9.
15. Brown P. Variant CJD transmission through blood: Risks to predictors and 'predictees'. Transfusion 2003; 43: 425-7.